What is the P/E ratio of Affimed 2025?
The Affimed P/E ratio is -0.51.
Access the world's leading financial data and tools
Subscribe for $2 
Overview
Profile
Affimed stock stock price, forecast, news, chart, split, dividend and analysis Affimed ariva, Affimed onvista, Affimed finanzen.net, Affimed aktienfinder, Affimed marketscreener, Affimed marketwatch, Affimed bloomberg, Affimed handelsblatt, Affimed wiwo, Affimed forum
AFMD
NL0015001ZQ0
A12BHU
Price
Price
1.28
Today +/-
-0.00
Today %
-0.11 %
TickerAFMD
ISINNL0015001ZQ0
WKNA12BHU
Affimed stock price
%
Weekly
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the Affimed stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the Affimed stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the Affimed stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze Affimed's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
Affimed Stock Price History
| Date | Affimed Price |
|---|---|
| 1/7/2025 | 1.28 undefined |
| 1/7/2025 | 1.28 undefined |
| 1/6/2025 | 1.31 undefined |
| 1/3/2025 | 1.32 undefined |
| 1/2/2025 | 1.32 undefined |
| 12/31/2024 | 1.15 undefined |
| 12/30/2024 | 1.19 undefined |
| 12/27/2024 | 1.24 undefined |
| 12/26/2024 | 1.22 undefined |
| 12/24/2024 | 1.19 undefined |
| 12/23/2024 | 1.14 undefined |
| 12/20/2024 | 1.14 undefined |
| 12/19/2024 | 1.14 undefined |
| 12/18/2024 | 1.22 undefined |
| 12/17/2024 | 1.44 undefined |
| 12/16/2024 | 2.03 undefined |
| 12/13/2024 | 2.05 undefined |
| 12/12/2024 | 2.08 undefined |
| 12/11/2024 | 2.15 undefined |
| 12/10/2024 | 2.20 undefined |
Affimed Revenue, EBIT, Net Income NL0015001ZQ0 · A12BHU
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Affimed, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Affimed from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Affimed’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Affimed. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Affimed’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Affimed’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Affimed’s growth potential.
Affimed Revenue, EBIT and net profit per share
| Date | Affimed Revenue | Affimed EBIT | Affimed Net Income |
|---|---|---|---|
| 2029e | 117.8 M undefined | -69.23 M undefined | -24.05 M undefined |
| 2028e | 54.3 M undefined | -114.52 M undefined | -34.62 M undefined |
| 2027e | 13.91 M undefined | -138.49 M undefined | -41.67 M undefined |
| 2026e | 11.77 M undefined | -93.16 M undefined | -37.35 M undefined |
| 2025e | 4.99 M undefined | -69.34 M undefined | -37.41 M undefined |
| 2024e | 2.28 M undefined | -65.15 M undefined | -60.87 M undefined |
| 2023 | 8.28 M undefined | -107.6 M undefined | -105.94 M undefined |
| 2022 | 41.35 M undefined | -88.22 M undefined | -86 M undefined |
| 2021 | 40.37 M undefined | -64.16 M undefined | -57.52 M undefined |
| 2020 | 28.36 M undefined | -34.85 M undefined | -41.37 M undefined |
| 2019 | 21.39 M undefined | -32.63 M undefined | -32.37 M undefined |
| 2018 | 23.74 M undefined | -21.06 M undefined | -19.48 M undefined |
| 2017 | 2.01 M undefined | -27.26 M undefined | -30.22 M undefined |
| 2016 | 6.31 M undefined | -32.04 M undefined | -32.22 M undefined |
| 2015 | 7.56 M undefined | -21.34 M undefined | -20.24 M undefined |
| 2014 | 3.38 M undefined | -8.18 M undefined | -259,000 undefined |
| 2013 | 5.09 M undefined | -15.7 M undefined | -26.1 M undefined |
| 2012 | 1.17 M undefined | -10.4 M undefined | -14.31 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2012 | 1.17 M EUR | -10.4 M EUR | -14.31 M EUR |
| 2013 | 5.09 M EUR | -15.7 M EUR | -26.1 M EUR |
| 2014 | 3.38 M EUR | -8.18 M EUR | -259,000 EUR |
| 2015 | 7.56 M EUR | -21.34 M EUR | -20.24 M EUR |
| 2016 | 6.31 M EUR | -32.04 M EUR | -32.22 M EUR |
| 2017 | 2.01 M EUR | -27.26 M EUR | -30.22 M EUR |
| 2018 | 23.74 M EUR | -21.06 M EUR | -19.48 M EUR |
| 2019 | 21.39 M EUR | -32.63 M EUR | -32.37 M EUR |
| 2020 | 28.36 M EUR | -34.85 M EUR | -41.37 M EUR |
| 2021 | 40.37 M EUR | -64.16 M EUR | -57.52 M EUR |
| 2022 | 41.35 M EUR | -88.22 M EUR | -86 M EUR |
| 2023 | 8.28 M EUR | -107.6 M EUR | -105.94 M EUR |
| 2024e | 2.28 M EUR | -65.15 M EUR | -60.87 M EUR |
| 2025e | 4.99 M EUR | -69.34 M EUR | -37.41 M EUR |
| 2026e | 11.77 M EUR | -93.16 M EUR | -37.35 M EUR |
| 2027e | 13.91 M EUR | -138.49 M EUR | -41.67 M EUR |
| 2028e | 54.3 M EUR | -114.52 M EUR | -34.62 M EUR |
| 2029e | 117.8 M EUR | -69.23 M EUR | -24.05 M EUR |
Affimed Income Statement, Balance Sheet, Cash Flow Statement
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 5 | 3 | 7 | 6 | 2 | 23 | 21 | 28 | 40 | 41 | 8 | 2 | 4 | 11 | 13 | 54 | 117 |
| - | 400.00 | -40.00 | 133.33 | -14.29 | -66.67 | 1,050.00 | -8.70 | 33.33 | 42.86 | 2.50 | -80.49 | -75.00 | 100.00 | 175.00 | 18.18 | 315.38 | 116.67 |
| 600.00 | 80.00 | 66.67 | 85.71 | 83.33 | 50.00 | 95.65 | 90.48 | 92.86 | 95.00 | 95.12 | 75.00 | 300.00 | 150.00 | 54.55 | 46.15 | 11.11 | 5.13 |
| 0 | 4 | 2 | 6 | 5 | 1 | 22 | 19 | 26 | 38 | 39 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| -14 | -26 | 0 | -20 | -32 | -30 | -19 | -32 | -41 | -57 | -86 | -105 | -60 | -37 | -37 | -41 | -34 | -24 |
| - | 85.71 | - | - | 60.00 | -6.25 | -36.67 | 68.42 | 28.13 | 39.02 | 50.88 | 22.09 | -42.86 | -38.33 | - | 10.81 | -17.07 | -29.41 |
| 2.22 | 2.22 | 2.4 | 3.33 | 3.32 | 4.38 | 6.05 | 6.42 | 8.35 | 11.95 | 14.24 | 14.94 | 0 | 0 | 0 | 0 | 0 | 0 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The Affimed Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Affimed is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Affimed stock margins NL0015001ZQ0 · A12BHU
The Affimed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Affimed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Affimed.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Affimed's sales revenue. A higher gross margin percentage indicates that the Affimed retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Affimed's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Affimed's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Affimed's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Affimed. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Affimed's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Affimed Margin History
| Affimed Gross margin | Affimed Profit margin | Affimed EBIT margin | Affimed Profit margin |
|---|---|---|---|
| 2029e | 83.7 % | -58.77 % | -20.42 % |
| 2028e | 83.7 % | -210.92 % | -63.76 % |
| 2027e | 83.7 % | -995.56 % | -299.57 % |
| 2026e | 83.7 % | -791.42 % | -317.26 % |
| 2025e | 83.7 % | -1,389.01 % | -749.45 % |
| 2024e | 83.7 % | -2,855.02 % | -2,667.55 % |
| 2023 | 83.7 % | -1,300.34 % | -1,280.22 % |
| 2022 | 94.83 % | -213.33 % | -207.98 % |
| 2021 | 94.67 % | -158.93 % | -142.5 % |
| 2020 | 93.9 % | -122.87 % | -145.86 % |
| 2019 | 92.77 % | -152.53 % | -151.3 % |
| 2018 | 95.2 % | -88.73 % | -82.06 % |
| 2017 | 50.55 % | -1,356.22 % | -1,503.63 % |
| 2016 | 83.72 % | -507.51 % | -510.23 % |
| 2015 | 88.07 % | -282.24 % | -267.64 % |
| 2014 | 75.04 % | -241.81 % | -7.66 % |
| 2013 | 86.06 % | -308.69 % | -513.05 % |
| 2012 | 53.11 % | -886.36 % | -1,220.29 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2012 | 53.11 % | -886.36 % | -1,220.29 % |
| 2013 | 86.06 % | -308.69 % | -513.05 % |
| 2014 | 75.04 % | -241.81 % | -7.66 % |
| 2015 | 88.07 % | -282.24 % | -267.64 % |
| 2016 | 83.72 % | -507.51 % | -510.23 % |
| 2017 | 50.55 % | -1,356.22 % | -1,503.63 % |
| 2018 | 95.2 % | -88.73 % | -82.06 % |
| 2019 | 92.77 % | -152.53 % | -151.3 % |
| 2020 | 93.9 % | -122.87 % | -145.86 % |
| 2021 | 94.67 % | -158.93 % | -142.5 % |
| 2022 | 94.83 % | -213.33 % | -207.98 % |
| 2023 | 83.7 % | -1,300.34 % | -1,280.22 % |
| 2024e | 83.7 % | -2,855.02 % | -2,667.55 % |
| 2025e | 83.7 % | -1,389.01 % | -749.45 % |
| 2026e | 83.7 % | -791.42 % | -317.26 % |
| 2027e | 83.7 % | -995.56 % | -299.57 % |
| 2028e | 83.7 % | -210.92 % | -63.76 % |
| 2029e | 83.7 % | -58.77 % | -20.42 % |
Affimed Stock Sales Revenue, EBIT, Earnings per Share NL0015001ZQ0 · A12BHU
The Affimed earnings per share therefore indicates how much revenue Affimed has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
25 Years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Affimed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Affimed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Affimed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Affimed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
Affimed Revenue, EBIT and net profit per share
| Date | Affimed Sales per Share | Affimed EBIT per share | Affimed Earnings per Share |
|---|---|---|---|
| 2029e | 7.73 undefined | 0 undefined | -1.58 undefined |
| 2028e | 3.57 undefined | 0 undefined | -2.27 undefined |
| 2027e | 0.91 undefined | 0 undefined | -2.74 undefined |
| 2026e | 0.77 undefined | 0 undefined | -2.45 undefined |
| 2025e | 0.33 undefined | 0 undefined | -2.46 undefined |
| 2024e | 0.15 undefined | 0 undefined | -4 undefined |
| 2023 | 0.55 undefined | -7.2 undefined | -7.09 undefined |
| 2022 | 2.9 undefined | -6.2 undefined | -6.04 undefined |
| 2021 | 3.38 undefined | -5.37 undefined | -4.81 undefined |
| 2020 | 3.4 undefined | -4.17 undefined | -4.96 undefined |
| 2019 | 3.33 undefined | -5.08 undefined | -5.04 undefined |
| 2018 | 3.92 undefined | -3.48 undefined | -3.22 undefined |
| 2017 | 0.46 undefined | -6.22 undefined | -6.9 undefined |
| 2016 | 1.9 undefined | -9.65 undefined | -9.7 undefined |
| 2015 | 2.27 undefined | -6.42 undefined | -6.09 undefined |
| 2014 | 1.41 undefined | -3.41 undefined | -0.11 undefined |
| 2013 | 2.29 undefined | -7.06 undefined | -11.74 undefined |
| 2012 | 0.53 undefined | -4.68 undefined | -6.44 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2012 | 0.53 EUR | -4.68 EUR | -6.44 EUR |
| 2013 | 2.29 EUR | -7.06 EUR | -11.74 EUR |
| 2014 | 1.41 EUR | -3.41 EUR | -0.11 EUR |
| 2015 | 2.27 EUR | -6.42 EUR | -6.09 EUR |
| 2016 | 1.9 EUR | -9.65 EUR | -9.7 EUR |
| 2017 | 0.46 EUR | -6.22 EUR | -6.9 EUR |
| 2018 | 3.92 EUR | -3.48 EUR | -3.22 EUR |
| 2019 | 3.33 EUR | -5.08 EUR | -5.04 EUR |
| 2020 | 3.4 EUR | -4.17 EUR | -4.96 EUR |
| 2021 | 3.38 EUR | -5.37 EUR | -4.81 EUR |
| 2022 | 2.9 EUR | -6.2 EUR | -6.04 EUR |
| 2023 | 0.55 EUR | -7.2 EUR | -7.09 EUR |
| 2024e | 0.15 EUR | 0 EUR | -4 EUR |
| 2025e | 0.33 EUR | 0 EUR | -2.46 EUR |
| 2026e | 0.77 EUR | 0 EUR | -2.45 EUR |
| 2027e | 0.91 EUR | 0 EUR | -2.74 EUR |
| 2028e | 3.57 EUR | 0 EUR | -2.27 EUR |
| 2029e | 7.73 EUR | 0 EUR | -1.58 EUR |
Affimed business model
Affimed is one of the most popular companies on Eulerpool.com.
Affimed Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
Affimed historical P/E ratio, EBIT multiple, and P/S ratio
Affimed shares outstanding NL0015001ZQ0 · A12BHU
The number of shares was Affimed in 2024 — This indicates how many shares 14.94 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Affimed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Affimed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Affimed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Affimed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2012 | 2.22 M Aktien |
| 2013 | 2.22 M Aktien |
| 2014 | 2.4 M Aktien |
| 2015 | 3.33 M Aktien |
| 2016 | 3.32 M Aktien |
| 2017 | 4.38 M Aktien |
| 2018 | 6.05 M Aktien |
| 2019 | 6.42 M Aktien |
| 2020 | 8.35 M Aktien |
| 2021 | 11.95 M Aktien |
| 2022 | 14.24 M Aktien |
| 2023 | 14.94 M Aktien |
| 2024e | 14.94 M Aktien |
| 2025e | 14.94 M Aktien |
| 2026e | 14.94 M Aktien |
| 2027e | 14.94 M Aktien |
| 2028e | 14.94 M Aktien |
| 2029e | 14.94 M Aktien |
Affimed stock splits
In Affimed's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Affimed.
Affimed latest earnings and earnings surprises
| Date | EPS Estimate | EPS Actual | Quarterly report |
|---|---|---|---|
| 9/30/2024 | -0.96 | -0.94 (1.76 %) | 2024 Q3 |
| 6/30/2024 | -0.91 | -1.01 (-10.88 %) | 2024 Q2 |
| 3/31/2024 | -1.46 | -1.27 (13.01 %) | 2024 Q1 |
| 12/31/2023 | -1.57 | -1.35 (14.22 %) | 2023 Q4 |
| 9/30/2023 | -1.88 | -1.6 (14.78 %) | 2023 Q3 |
| 6/30/2023 | -1.93 | -2 (-3.39 %) | 2023 Q2 |
| 3/31/2023 | -1.99 | -2.1 (-5.32 %) | 2023 Q1 |
| 12/31/2022 | -1.98 | -2.2 (-10.99 %) | 2022 Q4 |
| 9/30/2022 | -1.8 | -1.1 (38.87 %) | 2022 Q3 |
| 6/30/2022 | -1.71 | -1.3 (23.77 %) | 2022 Q2 |
1
2
3
4
...
5
Eulerpool ESG Scorecard© for the Affimed stock
Eulerpool World ESG Rating (EESG©)
59/ 100
🌱 Environment
60
👫 Social
90
🏛️ Governance
28
Environment
Scope 1 - Direct Emissions | |
Scope 2 - Indirect emissions from purchased energy | |
Scope 3 - Indirect emissions within the value chain | |
Total CO₂ emissions | |
| CO₂ reduction strategy | |
| Coal energy | |
| Nuclear power | |
| Animal experiments | |
| Fur & Leather | |
| Pesticides | |
| Palm Oil | |
| Tobacco | |
| Genetically modified organisms | |
| Climate concept | |
| Sustainable forestry | |
| Recycling regulations | |
| Environmentally friendly packaging | |
| Hazardous substances | |
| Fuel consumption and efficiency | |
| Water consumption and efficiency |
Social
| Percentage of female employees | |
| Percentage of women in management | |
| Percentage of Asian employees | |
| Share of Asian management | |
| Percentage of Hispanic/Latino employees | |
| Hispano/Latino Management share | |
| Percentage of Black employees | |
| Black Management Share | |
| Percentage of white employees | |
| White Management Share | |
| Adult content | |
| Alcohol | |
| Weapons | |
| Firearms | |
| Gambling | |
| Military contracts | |
| Human rights concept | |
| Privacy concept | |
| Occupational health and safety | |
| Catholic |
Governance (Corporate Governance)
| Environmental reporting | |
| Stakeholder Engagement | |
| Call Back Policies | |
| Antitrust law |
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Affimed shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 9.75639 % | Ridgeback Capital Management, L.P. | 1,485,898 | 197,637 | 12/31/2023 |
| 6.07091 % | 683 Capital Management LLC | 924,600 | 274,600 | 10/14/2024 |
| 5.33487 % | Gilde Healthcare Partners B.V. | 812,500 | 812,500 | 3/15/2024 |
| 2.90643 % | New Enterprise Associates (NEA) | 442,649 | 0 | 6/30/2024 |
| 2.44772 % | Millennium Management LLC | 372,788 | 350,806 | 6/30/2024 |
| 2.15199 % | Point72 Asset Management, L.P. | 327,748 | -94,834 | 6/30/2024 |
| 2.09899 % | Hoess (Adi Ph.D.) | 319,676 | 66,083 | 3/15/2024 |
| 1.82840 % | Morgan Stanley & Co. LLC | 278,465 | 152,853 | 6/30/2024 |
| 1.09297 % | Eversept Partners, LP | 166,460 | 0 | 6/30/2024 |
| 0.95559 % | Fischer (Wolfgang) | 145,537 | 37,291 | 3/15/2024 |
1
2
3
4
5
...
10
Affimed Executives and Management Board
Dr. Adi Hoess
(61)Affimed Chief Executive Officer, Member of the Management Board
Compensation 2.6 M
Mr. Angus Smith
(40)Affimed Chief Financial Officer, Co-President Affimed Inc, Member of the Management Board
Compensation 1.71 M
Dr. Wolfgang Fischer
(59)Affimed Chief Operating Officer, Member of the Management Board
Compensation 1.6 M
Dr. Arndt Schottelius
(56)Affimed Chief Scientific Officer, Member of the Management Board
Compensation 1.56 M
Ms. Denise Mueller
(54)Affimed Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Compensation 1.5 M
1
2
3
Affimed Supply Chain
| Name | Relationship | Two-week correlation | One-month correlation | Three-Month Correlation | Six-Month Correlation | One Year Correlation | Two-Year Correlation |
|---|---|---|---|---|---|---|---|
| SupplierCustomer | 0,60 | 0,77 | -0,26 | -0,35 | -0,31 | ||
| SupplierCustomer | 0,39 | 0,55 | 0,84 | 0,79 | 0,91 | -0,13 | |
| SupplierCustomer | -0,17 | 0,54 | 0,70 | 0,80 | 0,76 | ||
 Novo Nordisk B | SupplierCustomer | -0,20 | 0,44 | -0,33 | -0,09 | -0,62 | -0,17 |
| SupplierCustomer | -0,20 | -0,77 | -0,84 | -0,25 | -0,36 | -0,04 | |
| SupplierCustomer | -0,28 | -0,12 | -0,23 | -0,31 | -0,59 | 0,02 | |
| SupplierCustomer | -0,43 | -0,39 | -0,73 | -0,75 | -0,50 | -0,43 |
1
Most common questions regarding Affimed
What is the P/S ratio of Affimed 2025?
The Affimed P/S ratio is 3.82.
What is the Quality Investing of Affimed?
The Quality Investing for Affimed is 4/10.
What is the revenue of Affimed 2025?
The expected Affimed revenue is 4.99 M EUR.
How high is the profit of Affimed 2025?
The expected Affimed profit is -37.41 M EUR.
What is the business model of Affimed
No history available for Affimed.
What is the Affimed dividend?
Affimed pays a dividend of 0 EUR distributed over payouts per year.
How often does Affimed pay dividends?
The dividend cannot currently be calculated for Affimed or the company does not pay out a dividend.
What is the Affimed ISIN?
The ISIN of Affimed is NL0015001ZQ0.
What is the Affimed WKN?
The WKN of Affimed is A12BHU.
What is the Affimed ticker?
The ticker of Affimed is AFMD.
How much dividend does Affimed pay?
Over the past 12 months, Affimed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Affimed is expected to pay a dividend of 0 EUR.
What is the dividend yield of Affimed?
The current dividend yield of Affimed is .
When does Affimed pay dividends?
Affimed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Affimed?
Affimed paid dividends every year for the past 0 years.
What is the dividend of Affimed?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Affimed located?
Affimed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Affimed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Affimed from 1/8/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 1/8/2025.
When did Affimed pay the last dividend?
The last dividend was paid out on 1/8/2025.
What was the dividend of Affimed in the year 2024?
In the year 2024, Affimed distributed 0 EUR as dividends.
In which currency does Affimed pay out the dividend?
The dividends of Affimed are distributed in EUR.
Affimed stock
Sector
Health
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website Affimed
Country
Germany 🇩🇪
Currency
EUR
Initial public offering
Sep 12, 2014
GOSIN
Global Open Securities Identification Number
Cusip
N01045108
Sedol
BQQF5R2
Market capitalization
Quality Investing
4 / 10Details
PEG
0.02
P/E ratio
Forward P/E ratio
-0.32
P/S ratio
Forward P/S ratio
1.62
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
Affimed Peer Group
Affimed Eulerpool News
Affimed News
Affimed Ticker
| Stock Exchange | Affimed Ticker |
|---|---|
| DÜSSELDORF | A28.DU |
| FRANKFURT | A28.F |
| LONDON | 0HL9.L |
| LONDON STOCK EXCHANGE | 0HL9.L |
| MUNICH | A28.MU |
| NASDAQ | AFMD |
| SIX | A28.SW |
All fundamentals about Affimed
Our stock analysis for Affimed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Affimed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
